CYP2C19 and metabolic dysfunction-associated steatotic liver disease: Importantly, NAS and steatohepatitis were dropped from the multiple regression model, suggesting worsening fibrosis as possibly the most important histological NAFLD feature in describing CYP2C19 downregulation.